Aaron Grossman
Neurology · Cincinnati, OHNPI 1104066497
Payments from drug & device makers
Across 51 payments — averaging $672.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$15K
- Cordis US CORP.$13K
- Penumbra, Inc.$2K
- Biosense Webster, Inc.$2K
- Medical Device Business Services, Inc.$1K
- Medtronic$757
- plus $1K from 10 others
What the payments were for
- Consulting fees$13,67640%
- Speaking & faculty fees$14,52042%
- Travel & lodging$3,0909%
- Food & beverage$3,0069%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 14 | $14,966 |
| Cordis US CORP. | 4 | $12,942 |
| Penumbra, Inc. | 2 | $1,646 |
| Biosense Webster, Inc. | 1 | $1,500 |
| Medical Device Business Services, Inc. | 8 | $1,310 |
| Medtronic(2 entities) | 10 | $757 |
| Johnson & Johnson | 3 | $267 |
| Route 92 Medical, Inc. | 1 | $251 |
| Qapel Medical Inc | 1 | $199 |
| Imperative Care, Inc | 1 | $150 |
| Viz.ai, Inc. | 1 | $117 |
| Kaneka Medical America LLC | 1 | $86 |
| Scientia Vascular | 1 | $33 |
| Cardiva Medical, Inc. | 1 | $27 |
| Microvention, Inc. | 1 | $22 |
| Abbott | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Activase$14,784
- PRECISE PRO RX$12,176
- Carto 3 System$1,500
- Penumbra System$1,500
- PULSERIDER$968
- TRUFILL$968
- ANGIOGUARD$670
- Pipeline$513
- ZOOM REPERFUSION CATHETER$150
- ZOOM 88-T LARGE DISTAL PLATFORM$150
- RED 72$146
- SOLITAIRE X$146
- Viz.AI LVO$117
- CEREPAK UNIFORM$104
- Embotrap$104
How this compares
$34,292 in reported general payments places this provider in the 75th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 11 | $4,550 |
| ClopidogrelClopidogrel Bisulfate | 33 | $312 |
| Verapamil ErVerapamil Hcl | 11 | $130 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cincinnati
- Aram ZabetiCincinnati$5.3M
- Hani KushlafCincinnati$1.9M
- Alberto EspayCincinnati$785K
- Brandon ForemanCincinnati$677K
- Andrew DukerCincinnati$620K
- Michelle BowmanCincinnati$419K
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.